XML 98 R34.htm IDEA: XBRL DOCUMENT
v3.20.1

Segment Information (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2019
Segment Reporting [Abstract] |
Segment Information | The following tables present certain operations information by reportable segment.
|  | Life Sciences |  | Mobile Solutions |  | Power Solutions |  | Corporate and Consolidations |  | Total
Year Ended December 31, 2019 |  |  |  |  |  |  |  |  |  |
Net sales |  | $ | 359,732 |  |  | $ | 297,749 |  |  | $ | 192,100 |  |  | $ | (2,130 | ) | (a) | $ | 847,451 |
Depreciation and amortization |  | 46,905 |  |  | 27,146 |  |  | 15,301 |  |  | 2,494 |  |  | 91,846 |
Income (loss) from operations |  | 28,157 |  |  | 9,553 |  |  | 13,881 |  |  | (41,702 | ) |  | $ | 9,889 |
Interest expense |  |  |  |  |  |  |  |  |  | (57,155 | )
Other |  |  |  |  |  |  |  |  |  | (4,433 | )
Loss before provision for income taxes and share of net income from joint venture |  |  |  |  |  |  |  |  |  | $ | (51,699 | )
Share of net income from joint venture |  | $ | — |  |  | $ | 1,681 |  |  | $ | — |  |  | $ | — |  |  | $ | 1,681 |
Expenditures for long-lived assets |  | 21,445 |  |  | 24,969 |  |  | 4,457 |  |  | 3,132 |  |  | 54,003 |
Total assets |  | 811,526 |  |  | 373,256 |  |  | 310,545 |  |  | 46,657 |  | (b) | 1,541,984 |
|  | Life Sciences |  | Mobile Solutions |  | Power Solutions |  | Corporate and Consolidations |  | Total
Year Ended December 31, 2018 |  |  |  |  |  |  |  |  |  |
Net sales |  | $ | 248,173 |  |  | $ | 335,037 |  |  | $ | 189,778 |  |  | $ | (2,331 | ) | (a) | $ | 770,657 |
Depreciation and amortization |  | 28,091 |  |  | 26,217 |  |  | 14,753 |  |  | 2,067 |  |  | 71,128 |
Goodwill impairment |  | — |  |  | 73,442 |  |  | 109,100 |  |  | — |  |  | 182,542 |
Income (loss) from operations |  | 19,136 |  |  | (55,079 | ) |  | (95,115 | ) |  | (48,806 | ) |  | $ | (179,864 | )
Interest expense |  |  |  |  |  |  |  |  |  | (61,243 | )
Other |  |  |  |  |  |  |  |  |  | (20,903 | )
Loss before benefit for income taxes and share of net income from joint venture |  |  |  |  |  |  |  |  |  | $ | (262,010 | )
Share of net income from joint venture |  | $ | — |  |  | $ | (14,390 | ) |  | $ | — |  |  | $ | — |  |  | $ | (14,390 | )
Expenditures for long-lived assets |  | 14,645 |  |  | 36,660 |  |  | 6,459 |  |  | 6,272 |  |  | 64,036 |
Total assets |  | 802,770 |  |  | 354,542 |  |  | 297,947 |  |  | 45,643 |  | (b) | 1,500,902 |
|  | Life Sciences |  | Mobile Solutions |  | Power Solutions |  | Corporate and Consolidations |  | Total
Year Ended December 31, 2017 |  |  |  |  |  |  |  |  |  |
Net sales |  | $ | 98,329 |  |  | $ | 336,852 |  |  | $ | 186,602 |  |  | $ | (1,990 | ) | (a) | $ | 619,793 |
Depreciation and amortization |  | 12,088 |  |  | 24,491 |  |  | 14,657 |  |  | 1,170 |  |  | 52,406 |
Income (loss) from operations |  | 13,271 |  |  | 33,071 |  |  | 23,440 |  |  | (38,002 | ) |  | $ | 31,780 |
Interest expense |  |  |  |  |  |  |  |  |  | (52,085 | )
Other |  |  |  |  |  |  |  |  |  | (39,902 | )
Loss before benefit for income taxes and share of net income from joint venture |  |  |  |  |  |  |  |  |  | $ | (60,207 | )
Share of net income from joint venture |  | $ | — |  |  | $ | 5,211 |  |  | $ | — |  |  | $ | — |  |  | $ | 5,211 |
Expenditures for long-lived assets |  | — |  |  | 24,056 |  |  | 5,443 |  |  | 6,907 |  |  | 36,406 |
Total assets |  | 353,208 |  |  | 427,027 |  |  | 385,558 |  |  | 307,916 |  |  | 1,473,709 |
_______________________________ (a) Includes eliminations of intersegment transactions which occur during the ordinary course of business. (b) Total assets in Mobile Solutions includes $21.8 million and $20.4 million as of December 31, 2019 and 2018, respectively, related to the investment in our 49% owned joint venture (Note 11). The following table summarizes the net sales and income (loss) from operations from acquisitions in the Life Sciences and Power Solutions groups for the years ended December 31, 2018 and 2017.
|  | Year Ended December 31,
|  | 2018 |  | 2017
Net sales |  |  |  |
Paragon Medical |  | $ | 116,998 |  |  | $ | — |
Other |  | 42,636 |  |  | 6,682 |
Income (loss) from operations |  |  |  |
Paragon Medical |  | $ | 8,086 |  |  | $ | — |
Other |  | 1,816 |  |  | (458 | )
Summary of Sales to External Customers and Long-Lived Tangible Assets by Geographical Region | The following table summarizes long-lived tangible assets by geographical region.
|  | Property, Plant, and Equipment, Net As of December 31,
|  | 2019 |  | 2018
United States |  | $ | 250,163 |  |  | $ | 235,975 |
Europe |  | 54,829 |  |  | 50,143 |
Asia |  | 43,128 |  |  | 42,657 |
Mexico |  | 1,388 |  |  | 7,647 |
S. America |  | 25,005 |  |  | 24,606 |
All foreign countries |  | $ | 124,350 |  |  | $ | 125,053 |
Total |  | $ | 374,513 |  |  | $ | 361,028 |

X
- Definition Tabular disclosure of the names of foreign countries in which material long-lived assets other than financial instruments, long-term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, and deferred tax assets are located, and amount of such long-lived assets located in that country or foreign geographic area. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 41 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e9038-108599 + Details
Name: | us-gaap_ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 25 -URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8813-108599 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=108376223&loc=d3e13816-109267 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 21 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8721-108599 Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8906-108599 + Details
Name: | us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration